No profile data available.
Boston Scientific Corporation (BSX) is a healthcare company in the various healthcare equipment manufacturing industry, based in Marlborough, United States, with about 59,000 full-time employees.
It reported revenue of $20.07 billion for fiscal year 2025, and net income of $2.90 billion. Its largest business segment, Cardiovascular, brought in 66% of segment revenue in fiscal year 2025; United States was the largest region with 64%. Its market capitalization was $61.93 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.
Boston Scientific reported $20.07 billion in revenue for fiscal year 2025.
Cardiovascular, with $13.25 billion or 66% of segment revenue in fiscal year 2025. Next: MedSurg (34%).
United States: 64% of revenue by region in fiscal year 2025, followed by Europe, Middle East and Africa (17%).
$61.93 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (various healthcare equipment manufacturing) include Abbott Laboratories (ABT), Medtronic plc (MDT), Stryker Corporation (SYK), Becton, Dickinson and Company (BDX).